These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7552588)

  • 1. Inflammatory mediators and bronchopulmonary dysplasia.
    Groneck P; Speer CP
    Arch Dis Child Fetal Neonatal Ed; 1995 Jul; 73(1):F1-3. PubMed ID: 7552588
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates.
    Groneck P; Götze-Speer B; Oppermann M; Eiffert H; Speer CP
    Pediatrics; 1994 May; 93(5):712-8. PubMed ID: 8165067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent elastase/proteinase inhibitor imbalance during prolonged ventilation of infants with bronchopulmonary dysplasia: evidence for the role of nosocomial infections.
    Walti H; Tordet C; Gerbaut L; Saugier P; Moriette G; Relier JP
    Pediatr Res; 1989 Oct; 26(4):351-5. PubMed ID: 2797948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bronchoalveolar oxyradical inflammatory elements herald bronchopulmonary dysplasia.
    Contreras M; Hariharan N; Lewandoski JR; Ciesielski W; Koscik R; Zimmerman JJ
    Crit Care Med; 1996 Jan; 24(1):29-37. PubMed ID: 8565534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in bronchoalveolar lavage fluid from premature infants who develop chronic lung disease.
    Kotecha S; Chan B; Azam N; Silverman M; Shaw RJ
    Arch Dis Child Fetal Neonatal Ed; 1995 Mar; 72(2):F90-6. PubMed ID: 7712280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory mediators in CF patients.
    Hilliard JB; Konstan MW; Davis PB
    Methods Mol Med; 2002; 70():409-31. PubMed ID: 11917540
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased leukocyte elastase of the tracheal aspirate at birth and neonatal pulmonary emphysema.
    Fujimura M; Kitajima H; Nakayama M
    Pediatrics; 1993 Oct; 92(4):564-9. PubMed ID: 8414828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cromolyn sodium prophylaxis inhibits pulmonary proinflammatory cytokines in infants at high risk for bronchopulmonary dysplasia.
    Viscardi RM; Hasday JD; Gumpper KF; Taciak V; Campbell AB; Palmer TW
    Am J Respir Crit Care Med; 1997 Nov; 156(5):1523-9. PubMed ID: 9372670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of IL-8, SP-A and TGF-beta1 in bronchoalveolar lavage fluid of neonates with bronchopulmonary dysplasia].
    Liu DY; Wu J; Zhang XY; Feng ZC
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 Jun; 12(6):444-6. PubMed ID: 20540853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary inflammation and bronchopulmonary dysplasia.
    Speer CP
    J Perinatol; 2006 May; 26 Suppl 1():S57-62; discussion S63-4. PubMed ID: 16625227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nutrition and bronchopulmonary dysplasia.
    Wilson DC; McClure G; Halliday HL; Reid MM; Dodge JA
    Arch Dis Child; 1991 Jan; 66(1 Spec No):37-8. PubMed ID: 1996890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monocyte chemoattractant protein-1 and interleukin-8 are increased in bronchopulmonary dysplasia: relation to isolation of Ureaplasma urealyticum.
    Baier RJ; Loggins J; Kruger TE
    J Investig Med; 2001 Jul; 49(4):362-9. PubMed ID: 11478413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of inflammation in the pathogenesis of bronchopulmonary dysplasia.
    Pierce MR; Bancalari E
    Pediatr Pulmonol; 1995 Jun; 19(6):371-8. PubMed ID: 7567218
    [No Abstract]   [Full Text] [Related]  

  • 14. Neutrophils and myocardial reperfusion injury.
    Williams FM
    Pharmacol Ther; 1996; 72(1):1-12. PubMed ID: 8981567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-33 (IL-33) Increases Hyperoxia-Induced Bronchopulmonary Dysplasia in Newborn Mice by Regulation of Inflammatory Mediators.
    Tang X
    Med Sci Monit; 2018 Sep; 24():6717-6728. PubMed ID: 30244258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory bronchopulmonary response of preterm infants with microbial colonisation of the airways at birth.
    Groneck P; Goetze-Speer B; Speer CP
    Arch Dis Child Fetal Neonatal Ed; 1996 Jan; 74(1):F51-5. PubMed ID: 8653437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-kappaB in tracheal lavage fluid from intubated premature infants: association with inflammation, oxygen, and outcome.
    Bourbia A; Cruz MA; Rozycki HJ
    Arch Dis Child Fetal Neonatal Ed; 2006 Jan; 91(1):F36-9. PubMed ID: 16049063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of chorioamnionitis on the development of bronchopulmonary dysplasia triggered by postnatal systemic inflammation in neonatal rats.
    Choi CW; Lee J; Oh JY; Lee SH; Lee HJ; Kim BI
    Pediatr Res; 2016 Feb; 79(2):287-94. PubMed ID: 26551413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meter-dosed, inhaled beclomethasone attenuates bronchoalveolar oxyradical inflammation in premature infants at risk for bronchopulmonary dysplasia.
    Zimmerman JJ; Gabbert D; Shivpuri C; Kayata S; Ciesielski W; Miller J; Peters ME; Eissenstat RP; Shen G
    Am J Perinatol; 1998; 15(10):567-76. PubMed ID: 9926878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated type IV collagen in bronchoalveolar lavage fluid from infants with bronchopulmonary dysplasia.
    Ohki Y; Kato M; Kimura H; Nako Y; Tokuyama K; Morikawa A
    Biol Neonate; 2001 Jan; 79(1):34-8. PubMed ID: 11150828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.